Chai Discovery co-founders Joshua Meier (L) and Jack Dent
June 30, 2025 06:00 AM EDTUpdated 09:02 AM
Startups
AI

Ope­nAI-backed start­up re­leas­es new AI mod­els, claim­ing top per­for­mance in mak­ing an­ti­bod­ies

Andrew Dunn

Senior Biopharma Correspondent

A San Fran­cis­co start­up said Mon­day that its newest AI mod­els pro­duced de no­vo an­ti­bod­ies in the lab with far greater suc­cess rates than oth­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­ple Tree Part­ner­s' biotechs 'face im­mi­nent col­lapse' as firm bat­tles Russ­ian in­vestor in court

Ab­b­Vie bags Cap­stan’s in vi­vo CAR-T work with $2.1B buy­out deal

Am­gen’s stom­ach can­cer drug boosts sur­vival in Phase 3, but oc­u­lar side ef­fects leave ques­tions

IN­mune Bio’s Alzheimer’s drug fails Phase 2; Bridge­Bio sells some AT­TR-CM roy­al­ties

Hik­ma pledges $1B to ex­pand US man­u­fac­tur­ing pres­ence

Mod­er­na's Phase 3 flu vac­cine ef­fi­ca­cy in line with com­peti­tors, tee­ing up new sub­mis­sions

A service from the Financial Times